BMO Capital Has Just Reaffirmed $31 Target Price Per Share on Wright Medical Group NV (NASDAQ:WMGI) stock, While They’ve Also Reiterated Their Outperform Rating

November 14, 2017 - By Maria Brooks

 BMO Capital Has Just Reaffirmed $31 Target Price Per Share on Wright Medical Group NV (NASDAQ:WMGI) stock, While They’ve Also Reiterated Their Outperform Rating

Wright Medical Group NV (NASDAQ:WMGI) Rating Reaffirmed

Recently, In a note issued to clients on 2 November, Wright Medical Group NV (NASDAQ:WMGI) shares have had their Outperform Rating kept by stock research analysts at BMO Capital, who currently has a $31 target price on firm. This target by BMO Capital gives the possibile upside of 30.91 % from the last stock close price.

Wright Medical Group Inc (NASDAQ:WMGI) Ratings Coverage

Among 18 analysts covering Wright Medical Group (NASDAQ:WMGI), 14 have Buy rating, 0 Sell and 4 Hold. Therefore 78% are positive. Wright Medical Group has $3400 highest and $22 lowest target. $29.36’s average target is 23.99% above currents $23.68 stock price. Wright Medical Group had 33 analyst reports since August 20, 2015 according to SRatingsIntel. Needham maintained the shares of WMGI in report on Thursday, August 20 with “Hold” rating. The stock of Wright Medical Group Inc (NASDAQ:WMGI) earned “Buy” rating by Jefferies on Tuesday, October 10. The stock of Wright Medical Group Inc (NASDAQ:WMGI) earned “Hold” rating by Needham on Wednesday, February 15. The company was maintained on Thursday, June 29 by Jefferies. As per Thursday, September 3, the company rating was maintained by Needham. RBC Capital Markets maintained the shares of WMGI in report on Monday, October 2 with “Buy” rating. The firm has “Overweight” rating given on Thursday, November 2 by Barclays Capital. The rating was maintained by Brean Capital on Thursday, September 3 with “Buy”. The stock of Wright Medical Group Inc (NASDAQ:WMGI) earned “Hold” rating by Piper Jaffray on Wednesday, September 2. The firm has “Perform” rating by Oppenheimer given on Monday, November 30.

The stock increased 0.13% or $0.03 during the last trading session, reaching $23.68. About 307,874 shares traded. Wright Medical Group Inc (NASDAQ:WMGI) has risen 49.62% since November 14, 2016 and is uptrending. It has outperformed by 32.92% the S&P500.

Investors wait Wright Medical Group Inc (NASDAQ:WMGI) to report on February, 20. its quarterly earnings Wall Street analysts expect $0.03 earnings per share, up $0.09 or 150.00 % from last year’s $-0.06 same quarter earnings. This translates into $1.55M profit for WMGI giving the stock a 197.33 P/E. This is assuming the current $0.03 EPS is accurate. Wright Medical Group Inc’s Wall Street analysts see -118.75 % EPS growth, taking into account the $-0.16 EPS reproted in the previous quarter,

Wright Medical Group, Inc. is a global specialty orthopaedic company. The company has market cap of $1.22 billion. The Firm through Wright Medical Technology, Inc. and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients’ lifestyles. It currently has negative earnings. The Firm operates through three divisions: U.S., International and BioMimetic.

More notable recent Wright Medical Group Inc (NASDAQ:WMGI) news were published by: Seekingalpha.com which released: “Wright Medical Group NV (WMGI) Q1 2017 Results – Earnings Call Transcript” on May 04, 2017, also Globenewswire.com with their article: “Wright Medical Group NV to Present at Jefferies 2017 London Healthcare Conference” published on October 25, 2017, Seekingalpha.com published: “Back To The Future With Wright Medical” on February 23, 2017. More interesting news about Wright Medical Group Inc (NASDAQ:WMGI) were released by: Seekingalpha.com and their article: “Wright Can’t Get It Right” published on October 12, 2017 as well as Nasdaq.com‘s news article titled: “Wright Medical Group (WMGI) Q3 Earnings In Line, Sales Miss” with publication date: November 02, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: